Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick F Terry

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Science Translational Medicine|February 11, 2011
Power to the people: participant ownership of clinical trial dataSharon F Terry, Patrick F Terry
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|June 23, 2006
A consumer perspective on forensic DNA bankingSharon F Terry, Patrick F Terry
Genetic Testing and Molecular Biomarkers|February 10, 2016
To Pay or Not to Pay? Is that the Question?Patrick F Terry, Sharon F Terry
Genetic Testing and Molecular Biomarkers|May 29, 2009
A measure of truth in genetic testingKristi D Zonno, Patrick F Terry, Sharon F Terry
American Journal of Medical Genetics. Part A|June 15, 2011
Pseudoxanthoma elasticum: progress in diagnostics and research towards treatment : Summary of the 2010 PXE International Research MeetingJouni Uitto, Lionel Bercovitch, Sharon F Terry, et al.
Personalized Medicine|May 23, 2018
Genetic Alliance Registry and BioBank: a novel disease advocacy-driven research solutionSharon F Terry, Elizabeth J Horn, Joan Scott, et al.
The Journal of Investigative Dermatology|May 16, 2013
Pseudoxanthoma elasticum: progress in research toward treatment: summary of the 2012 PXE international research meetingJouni Uitto, Andras Váradi, Lionel Bercovitch, et al.
The Journal of Molecular Diagnostics : JMD|January 26, 2007
Development of a rapid, reliable genetic test for pseudoxanthoma elasticumYanggu Shi, Sharon F Terry, Patrick F Terry, et al.
Nature Reviews. Genetics|January 19, 2007
Advocacy groups as research organizations: the PXE International exampleSharon F Terry, Patrick F Terry, Katherine A Rauen, et al.
Science Translational Medicine|February 8, 2013
An end to the myth: there is no drug development pipelineKristin Baxter, Elizabeth Horn, Neely Gal-Edd, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Science Translational Medicine|February 11, 2011
Power to the people: participant ownership of clinical trial dataSharon F Terry, Patrick F Terry
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|June 23, 2006
A consumer perspective on forensic DNA bankingSharon F Terry, Patrick F Terry
Genetic Testing and Molecular Biomarkers|February 10, 2016
To Pay or Not to Pay? Is that the Question?Patrick F Terry, Sharon F Terry
Genetic Testing and Molecular Biomarkers|May 29, 2009
A measure of truth in genetic testingKristi D Zonno, Patrick F Terry, Sharon F Terry
American Journal of Medical Genetics. Part A|June 15, 2011
Pseudoxanthoma elasticum: progress in diagnostics and research towards treatment : Summary of the 2010 PXE International Research MeetingJouni Uitto, Lionel Bercovitch, Sharon F Terry, et al.
Personalized Medicine|May 23, 2018
Genetic Alliance Registry and BioBank: a novel disease advocacy-driven research solutionSharon F Terry, Elizabeth J Horn, Joan Scott, et al.
The Journal of Investigative Dermatology|May 16, 2013
Pseudoxanthoma elasticum: progress in research toward treatment: summary of the 2012 PXE international research meetingJouni Uitto, Andras Váradi, Lionel Bercovitch, et al.
The Journal of Molecular Diagnostics : JMD|January 26, 2007
Development of a rapid, reliable genetic test for pseudoxanthoma elasticumYanggu Shi, Sharon F Terry, Patrick F Terry, et al.
Nature Reviews. Genetics|January 19, 2007
Advocacy groups as research organizations: the PXE International exampleSharon F Terry, Patrick F Terry, Katherine A Rauen, et al.
Science Translational Medicine|February 8, 2013
An end to the myth: there is no drug development pipelineKristin Baxter, Elizabeth Horn, Neely Gal-Edd, et al.
Pageof 2